Top Stories UBS Downgrades Novo Nordisk Amid Rising Competition for Ozempic URGENT UPDATE: UBS has officially downgraded its rating for Novo Nordisk, the renowned Danish pharmaceutical company behind the blockbuster weight-loss drugs Ozempic and Wegovy.... Editorial17 hours ago